Cerebral Therapeutics
Aurora, US · Delaware corporation · 3 known investors
Founders & leadership
DA
Daniel AbramsChief Executive Officer
WL
SF
Stephen FarrNamed on SEC filing
MS
Investors · 3
Funding
SEC filings, press & company announcements$71M disclosed across 3 rounds · 2018–2022
- $40MSeries CJun 2022 · 2 sourcesSource ↗
▶$20MraisedJan 2020 · 6 investors · Other Health CareRule 506(b)
▶$20MraisedJan 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel AbramsExecutive Officer, Director
- Shah MahendraDirector
- Warren LammertDirector
- Stephen FarrDirector
- Weston NicholsDirector
- Matthew HammondDirector
- Offering amount
- $35M
- Amount sold
- $20M
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11MraisedMar 2019 · 4 investors · PharmaceuticalsRule 506(b)
▶$11MraisedMar 2019 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Warren LammertDirector
- Stephen FarrDirector
- Mahendra ShahDirector
- Daniel AbramsExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $11M
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Cerebral Therapeutics's investors?
- Cerebral Therapeutics's investors include Granite Point Capital, RA Capital, Vivo Capital.
- How much funding has Cerebral Therapeutics raised?
- Cerebral Therapeutics has disclosed $71M raised across 3 rounds.
- Where is Cerebral Therapeutics headquartered?
- Cerebral Therapeutics is headquartered in Aurora, US.